DNA
Ginkgo Bioworks Holdings
NYSE: DNA · HEALTHCARE · BIOTECHNOLOGY
$9.70
+14.66% today
Updated 2026-05-01
Market cap
$551.05M
P/E ratio
—
P/S ratio
3.24x
EPS (TTM)
$-5.64
Dividend yield
—
52W range
$5 – $18
Volume
1.2M
Ginkgo Bioworks Holdings (DNA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |